Interventional Cardiology Devices Market to be worth US$11.16 bn by 2022, Says TMR
May 23, 2018 09:38 ET
|
Transparency Market Research
Albany, NY, May 23, 2018 (GLOBE NEWSWIRE) -- The prevailing competitive landscape in the global interventional cardiology devices market is characterized by emerging forces of consolidation,...
Colibri Heart Valve Continues Enrollment in Clinical Feasibility Study of Second-Generation TAVI System
May 04, 2018 11:09 ET
|
Colibri Heart Valve, LLC
Broomfield, CO, May 04, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that the Colibri transcatheter aortic valve implantation...
Interventional Cardiology Devices Market is projected at a CAGR of 2.9% by 2022, globally: Transparency Market Research
February 06, 2018 07:47 ET
|
Transparency Market Research
Albany, NY, Feb. 06, 2018 (GLOBE NEWSWIRE) -- As per a market research report by Transparency Market Research, the world Interventional Cardiology Devices Market is considered to be extremely...
Colibri Heart Valve Receives European Patent for a Method of Making a Pre-packaged, Sterilized Dry Heart Valve, Pre-mounted on a Delivery Catheter
April 27, 2016 08:00 ET
|
Colibri Heart Valve LLC
BROOMFIELD, CO , April 27, 2016 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, has received notification from the European Patent Office that patent...
Interventional Cardiology Devices Market to Stand at US$11.2 bn by 2022, Bioabsorbable Vascular Stents to be Enormous Opportunity: Transparency Market Research
March 11, 2016 07:30 ET
|
Transparency Market Research
Albany, NY, March 11, 2016 (GLOBE NEWSWIRE) -- According to a latest study by Transparency Market Research (TMR), the global interventional cardiology devices market will firmly remain on the...
Colibri Heart Valve Announces Issuance of a Patent for a Pre-mounted, Pre-packaged, Sterilized Dry Heart Valve on a Delivery System
January 29, 2013 08:00 ET
|
Colibri Heart Valve LLC
BROOMFIELD, CO, Jan. 29, 2013 (GLOBE NEWSWIRE) -- Colibri Heart Valve,
LLC, a privately held medical device company, has been granted
yet another patent directed to prosthetic heart valves. ...